^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    NUMARZU-001

    i
    Associations
    News

    Trials

    Company:
    Hospital Clinic of Barcelona
    Drug class:
    Immunostimulant
    Related drugs:
    Associations
    News

    Trials

    Apply
    Treatment of Advanced or Metastatic Triple-negative Breast Cancer With Adoptive Therapy of PD1+ TILS (TILS001) (NCT05451784)
    Phase 1/2
    Fundacio Clinic Barcelona
    Recruiting
    Last update posted :
    11/24/2023
    Initiation :
    07/20/2022
    Primary completion :
    11/30/2025
    Completion :
    09/30/2027
    HER-2 • PD-1
    |
    HER-2 negative • PD-1 expression • PGR expression
    |
    NUMARZU-001